Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900068 · ClinicalTrials.gov registry record
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 9
- Enrollment target
NCT00900068 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 9 participants.
The verdict
NCT00900068 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about nausea and vomiting caused by cancer treatment. PURPOSE: This laboratory study is looking at blood samples from patients with cancer who were treated on a clinical trial to control nausea and vomiting during donor stem cell transplant.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900068
The ClinicalTrials.gov registry entry for NCT00900068 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900068 about?
NCT00900068 is a clinical study titled "Blood Samples From Patients on a Clinical Trial to CINV During HSCT". RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about nausea and vomiting caused by cancer treatment. PURPOSE: This laboratory study is looking at blood samples from patients with cancer who were treated on a clinical trial to control nau...
What is the current status of trial NCT00900068?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2008-08. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00900068?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00900068?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.